MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia. (Q54739281)

3 June 2018

title

MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia. (English)

1 reference

3 June 2018

1 reference

Akihiro Yokoyama

1

1 reference

3 June 2018

Takuya Yamashita

2

1 reference

3 June 2018

Eisuke Shiozawa

3

1 reference

3 June 2018

Atsuko Nagasawa

4

1 reference

3 June 2018

Junko Okabe-Kado

5

1 reference

3 June 2018

Tsuyoshi Nakamaki

6

1 reference

3 June 2018

Shigeru Tomoyasu

7

1 reference

3 June 2018

Fumihiko Kimura

8

1 reference

3 June 2018

Kazuo Motoyoshi

9

1 reference

3 June 2018

Yoshio Honma

10

1 reference

3 June 2018

Takashi Kasukabe

11

1 reference

3 June 2018

publication date

1 February 2004

1 reference

3 June 2018

published in

Leukemia Research

1 reference

3 June 2018

volume

28

1 reference

3 June 2018

issue

2

1 reference

3 June 2018

page(s)

149-157

1 reference

3 June 2018

Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Proline-rich sequences that bind to Src homology 3 domains with individual specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Modular binding domains in signal transduction proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Cyclin E is a target of WT1 transcriptional repression

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Evidence for a novel gene associated with low tumor metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Serum nm23-H1 protein as a prognostic factor in hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900189-9

7 January 2021

10.1016/S0145-2126(03)00189-9

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

14654079

1 reference

3 June 2018